Health-related litigation is on the rise.
From class action lawsuits against pharmaceutical companies to individual claims against medical device manufacturers, the volume and visibility of health-focused legal action have increased significantly over the past decade. For business leaders—even those outside the healthcare sector—this trend carries important implications.
What Is Driving the Increase
Several factors are converging to fuel the growth of health-related lawsuits. Greater consumer awareness, driven by social media and investigative journalism, means that safety issues are identified and publicized faster than ever.
Advances in medical research are uncovering links between products and health conditions that were previously unknown or poorly understood.
Legislative reforms in many states have expanded the window for filing personal injury and product liability claims. And a growing cultural emphasis on corporate accountability has made consumers more willing to take legal action when they believe they have been harmed.
Industries Most Affected
While the pharmaceutical and medical device industries are the most obvious targets, the trend extends further.
Companies in the consumer products, food and beverage, cosmetics, and industrial chemicals sectors have all faced increased litigation related to health effects. Businesses that use or produce substances with potential long-term health implications—such as certain chemicals, additives, or raw materials—should be particularly attentive to evolving research and regulatory guidance.
The Strategic Implications
For executives and board members, the rise of health-related litigation signals a need to reassess risk management strategies.
This means ensuring that product safety and regulatory compliance are standing agenda items at the leadership level, not afterthoughts. It means investing in proactive research and testing, particularly for products with long-term exposure profiles.
It means building relationships with outside legal counsel before a crisis occurs, rather than scrambling to find representation after one. And it means taking consumer complaints seriously as potential early indicators of larger problems.
The Insurance Dimension
Rising litigation also has implications for insurance costs. Companies in industries with high product liability exposure are seeing premiums increase, and some are finding it more difficult to obtain coverage at all.
Businesses that can demonstrate strong safety protocols, transparent adverse event reporting, and proactive risk mitigation are better positioned to negotiate favorable terms with insurers.
A Forward-Looking Approach
The companies that will navigate this environment most successfully are those that view health-related risk not as a cost to be minimized but as a core business consideration. Just as cybersecurity has moved from the IT department to the boardroom, product safety and health-related liability deserve the same elevation.
The businesses that lead in safety will be the ones that lead in their markets.
Help Law-related Links
Miller and Zois
Cavanaghlawgroup.com
Hercasematters.com
Cooneyconway.com
Motley Rice Law Firm